Lurbinectedin and atezolizumab performed better than atezolizumab alone as maintenance therapy for extensive-stage small cell lung cancer.

The UK Government is pushing itself to become a world leader in AI-powered drug discovery with new investments and global ...

BioTools Innovator (BTI), the first accelerator focused exclusively on life science tools and diagnostics startups, has selected 31 companies for its 2025 Accelerator program. These startups will ...

New project to make the UK a leader in AI-drug discovery, as Imperial College also partners with the World Economic Forum on ...

BioBridges adds job growth to the Raleigh-Durham area BioBridges, a leading provider of life sciences solutions, has brought more than 20 n ...

People around the world are set to benefit from new breakthroughs in AI-driven drug discovery to tackle previously untreatable diseases and transforming patient outcomes using British AI and research ...

As a mom to a child withhemophilia, stepping away from sports seemed to be the only way to keep him protected from a life-threatening bleed.

Market report includes a comprehensive understanding of current treatment practices, emerging HER2+ gastric cancer therapies, market share of individual therapies, and current and forecasted HER2+ ...